PRESTIGE CONSUMER HEALTHCARE INC. Proceeds from Long-Term Debt Issued
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Proceeds from Long-Term Debt Issued of $1.04 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. proceeds from issuance of long-term debt for the quarter ending 2026-06-30 was $1.04B.
- PRESTIGE CONSUMER HEALTHCARE INC. proceeds from issuance of long-term debt for the quarter ending 2025-06-30 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month |
|---|---|---|
| 2026-06-30 | $1.04B 10-Q · filed 2026-08-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-04 | |
| 2019-12-31 | $400.00M 10-Q · filed 2021-02-04 | |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |